Vaginal Dryness in Menopause

As estrogen falls, the lining thins to a few cell layers, loses its folds and stretch, produces less fluid, and its pH rises, which changes the bacteria living there. Blood flow and the nerve response that produce arousal and lubrication slow down. The urethra and bladder base, built from the same estrogen-sensitive tissue, thin too.

Unlike hot flashes, which are a brain response that eventually settles, this is a tissue change that continues as long as estrogen stays low. Women often notice it two to five years after their last period, later than the other symptoms, and don't connect it to menopause.

Left alone, it tends to progress. Treatment can restore the tissue at 55, 65 or 80, no matter how long you've had it.

Guidelines recommend it first for these symptoms.

Forms.

Options include a cream used with an applicator, a small tablet or insert placed with a finger or applicator, or a soft ring that sits in the vagina for three months. They all start with daily use for about two weeks, then drop to twice a week. Improvement begins within two to four weeks and continues for a few months.

Safety.

The doses are tiny, and the hormone acts on the tissue it touches; blood levels stay in the postmenopausal range. Because of that, it doesn't carry the risks associated with systemic hormone therapy, and a progestogen isn't needed to protect the uterus. It can be used indefinitely; symptoms return if it's stopped. Women with a history of breast cancer should have the conversation with their oncologist, but many can use it, particularly those not on aromatase inhibitors, and the major societies regard it as reasonable in that situation. The package insert carries the same warnings as systemic estrogen, which experts have long argued are not relevant at these doses; your clinician can explain the gap.

Systemic hormone therapy taken for hot flashes improves vaginal symptoms in many women, yet a sizeable minority still need a local treatment as well, and the standard advice is to add vaginal estrogen rather than raise the systemic dose. If you're on HRT and still dry or still getting infections, say so; it isn't a sign the HRT is failing.

The FDA issued a safety communication in 2018 warning that these devices have not been shown safe or effective for menopausal symptoms, and the better trials since have not shown an advantage over vaginal estrogen or even over sham treatment. They're expensive and not recommended outside research.

A video visit with a Golden Leaf Health clinician licensed in your state can prescribe vaginal estrogen or an alternative, with follow-up to check it's working. Book a first visit.